Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Apr 1, 2016
With the final goal to predict immunogenicity in patients treated with therapeutic antibodies, CD4 T cell response to therapeutic antibodies is investigated using cells collected in healthy donors. In the frame of ABIRISK we recently identified T cell epitopes in the therapeutic antibodies. We propose to discuss the relevance of this approach as a tool of prediction of immunogenicity.